Full Text View
Tabular View
Study Results
Related Studies
Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
This study has been completed.
Study NCT00324038   Information provided by Napp Pharmaceuticals Limited

First Received on May 9, 2006.   Last Updated on June 13, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoarthritis
More general conditions related to this trial
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
Buprenorphine
Codeine paracetamol
Additional drug interventions recognized in this trial
Acetaminophen
Codeine
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Antipyretics
Antitussive Agents
Central Nervous System Agents
Central Nervous System Depressants
Narcotic Antagonists
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Napp Pharmaceuticals Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services